Stuttering is a developmental speech disorder that occurs in 5% of children and can often lead to reduced overall functioning and quality of life due to the discomforts and symptoms associated with the disorder. There are currently no approved therapies and the medications being used to control stuttering are generally not well tolerated.
The development of a new treatment to effectively manage symptoms of stuttering and enhance speech fluency is essential. This study is researching the effects of a new medication on speech fluency in adults with a history of stuttering.
The study would require you to come to the clinic 14 times over the 15 weeks, roughly weekly visits. Visits will range between 15 mins to 90 mins each time you come in. Over the course of the study, we will check your medical history, draw blood, conduct an ECG and providing the medication. You will also need to complete a diary over the course of the study.
You will be paid for your time in the research study.
- Males aged between 18 to 50 years
- Has a history of stuttering that developed before 8 years old and has lasted for > 2 years
- BMI within the range of 22-30
- Relatively healthy